The CRO Perspective: Responding to the ICH M10 BMV Draft Guideline

Strategy for Implementation of 2018 FDA Bioanalytical Method Validation Guidance and Proactively Addressing the ICH M10 BMV Draft Guideline Internally and/or with Outsourcing Partners
Presented during APA 2019

Please complete the form below in order to access our resource:

"*" indicates required fields

Resource

The CRO Perspective: Responding to the ICH M10 BMV Draft Guideline

Please complete the form below in order to access our resource:

Alturas Analytics Partners in Pioneering Space Research with Polaris Dawn Mission

Alturas Analytics, Inc. Appoints Erik Burns as Chief Marketing and Business Strategy Officer

A Busy Fall Ahead with Alturas!

Meet with Alturas in Boston! | PBSS Workshop on Small Molecules

See you at ASMS! | Poster Presentation

19th Workshops on Recent Issues in Bioanalysis (WRIB)